|
|
|
| Analysis of effect of interventional treatment for brachiocephalic arteritis |
| LIU Yiren CUI Shijun GUO Lianrui QI Lixing QI Yixia GUO Jianming GU Yongquan▲ |
| Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China |
|
|
|
Abstract Objective To explore the clinical efficacy of endovascular angioplasty therapy for brachiocephalic arteritis. Methods The clinical data of 19 patients with brachiocephalic arteritis in Xuanwu Hospital, Capital Medical University from April 2005 to June 2017 were analyzed. All patients underwent balloon dilatation or stent implantation treatment. Results All patients underwent balloon dilatation or stent implantation, and the operation was successful. Balloon dilatation of common carotid artery, subclavian artery and vertebral artery were 11, 9 and 1 cases respectively, and stent implantation of nameless artery, common carotid artery, subclavian artery and vertebral artery were 1, 1, 2 and 1 case respectively. The follow-up period ranged from 12 to 98 months, of which 19 cases were followed up for more than 1 year, 17 cases for more than 2 years, 9 cases for more than 3 years to less than 5 years and 8 cases for more than 5 years. The symptoms of all patients were improved, including dizziness in 10 cases, blurred vision in 4 cases, dark quinone in 3 cases, unclear speech in 3 cases, and upper limb cooling in 2 cases. During the follow-up period, 1 patient died of cerebral hemorrhage 12 months after operation, 1 patient died of nasopharyngeal carcinoma 13 months after operation, and 1 patient lost follow-up 25 months after operation. Conclusion Endovascular angioplasty is safe and effective in the treatment of brachiocephalic arteritis.
|
|
|
|
|
|
[1] Numano F，Okawara M，Inomata H，et al. Takayasu′s arteritis [J]. Lancet，2000，356：1023-1025.
[2] Watts R，AI-Taiar A，Mooney J，et al. The epidemiology of Takayasuarteritis in the UK [J]. Rheumatology，2009，48， 1008-1011.
[3] Joseph J. Inflammatory ascending aortic disease：Perspectives from pahlology [J]. Thorac Cardiovasc Surg，2015， 149（2 Suppl）：S177-S183.
[4] Maksimowicz-Mckinnonk. New insights into the pathogene-sis and treatment of Takayasuarteritis [J]. Expert Rev Clin Immunol，2009，5（4）：445-449.
[5] 张斌，王影，王宝春.颈动脉粥样硬化斑块的彩色多普勒超声表现及其与脑梗死的关系研[J].现代中西医结合杂志，2017，26（6）：663-665.
[6] 李菁，朱孟铸，杨云娇，等．多发性大动脉炎合并活动性结核感染36例的病例对照研究[J].中华风湿病学杂志，2016，20（3）：176-180.
[7] Arend WP，Michel BA，Bloch DA，et al. The American College of Rheumatology 1990 criteria for the classification of Takayasuarteritis [J]. Arthnitis Rheum，1990，33：1129-1134.
[8] Perera AH，Youngstein T，Gibbs RGJ，et al. Optimizing the outcome of vascular intervention for Takayasu arteritis [J]. Br J Surg，2014，101（2）：43-50.
[9] 徐建萍，赵阳，李俊芳，等.大动脉炎合并中枢系统病变研究进展[J].山西医药杂志，2017，46（8）：900-902.
[10] 章新根，蔡海英.多发性大动脉炎中医治疗方剂用药规律挖掘分析及临床应用举隅[J].中国中药杂志，2016， 41（9）：1754-1758.
[11] 戴晓敏，董智慧，陈盛，等．大动脉炎诊断及活动性评价中国专家调查[J].复旦学报：医学版，2017，44（2）：127-133．
[12] 邹玉宝，蒋雄京.大动脉炎的研究现状与进展[J].中国循环杂志，2016，31（8）：822-824.
[13] 熊一频，胡国富.混合型多发性大动脉炎的外科治疗[J].中国普通外科杂志，2010，19（6），634-637.
[14] Chung JW，Kim HC，Choi YH，et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications： evaluation with spiral computed tomography angiography [J]. J Vasc Surg，2007，45（5）：906-914.
[15] 肖耀文，陈忠，杨耀国，等.大动脉炎手术与腔内治疗的效果及其影响因素[J].首都医科大学学报，2015，36（1）：45-52.
[16] Park HS，Do YS，Park KB，et al. Long term results of endovascular treatment in renal stenosis from Takayasu arteritis：angioplasty versus stent placement [J]. Eur J Radiol，2013，82（11）：1913-1918.
[17] 吴庆华，寇镭，陈忠，等.重症头臂型大动脉炎手术并发症的防治[J].中华普通外科杂志，2005，20（9）：552-554.
[18] 谷涌泉，张建，齐立行，等.颈动脉血流重建治疗重症多发性大动脉炎导致脑缺血[J].中华外科杂志，2009，47（9）：664-669.
[19] 谷涌泉，张建，齐立行，等.颈部动脉血流重建治疗重症多发性大动脉炎导致脑缺血的疗效分析[J].中国医师杂志，2016，18（11）：1611-1614.
[20] 汪忠镐，谷涌泉，张建，等.大动脉炎性脑缺血的临床对策[J].中华外科杂志，2006，44（1）：14-17.
[21] 董丽，林霞，葛健文，等.多发性大动脉炎合并脑梗死研究进展[J].中国现代医生，2017，55（20）：165-168. |
|
|
|
